AJMC October 21, 2024
Key Takeaways
- RSV presents a higher mortality risk than influenza B and similar to influenza A in older adults with comorbidities.
- The study found higher rates of pneumonia and dyspnea in patients with RSV compared with influenza A or B.
- Limitations include testing variability and lack of data on immunosuppressive disorders and vaccination status.
- The study emphasizes the need for better RSV testing, targeted treatment, and vaccination strategies for high-risk groups.
Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or influenza across Europe.
Respiratory syncytial virus (RSV) and influenza pose serious health risks, especially for older adults and those with comorbidities. Older adults hospitalized with RSV infections are at a...